Results 171 to 180 of about 235,302 (301)

Redefining Therapies for Drug‐Resistant Tuberculosis: Synergistic Effects of Antimicrobial Peptides, Nanotechnology, and Computational Design

Advanced Healthcare Materials, EarlyView.
Antimicrobial peptide (AMP)‐loaded nanocarriers provide a multifunctional strategy to combat drug‐resistant Mycobacterium tuberculosis. By enhancing intracellular delivery, bypassing efflux pumps, and disrupting bacterial membranes, this platform restores phagolysosome fusion and macrophage function.
Christian S. Carnero Canales, Jessica Ingrid Marquez Cazorla, Renzo Marianito Marquez Cazorla, Aline Martins dos Santos, Jonatas Lobato Duarte, Letícia Oliveira Catarin Nunes, Túlio Custódio Reis, Lara Cerazi Salvador, Norival Alves Santos‐Filho, Rafael Miguel Sábio, Hélder A. Santos, Fernando Rogério Pavan   +11 more
wiley   +1 more source

Debunking myths in pulmonary function testing

Canadian Journal of Respiratory Therapy, 2017
Jeffrey M Haynes
doaj  

Perspectives on Using Race in Pulmonary Function Testing: A National Survey Fellows and Program Directors. [PDF]

Respir Care
Banerjee D, Aijaz S, Nassikas NJ, Singh P, Lakshman S, Boyd C, Brown Q, Mathew A, Rosen RK, Lantini R, Andrea SB, Walsh SR, Gartman EJ, Levinson A, Carino G, Braun L.   +15 more
europepmc   +1 more source

The Quantitative Computed Tomography Techniques are Alternate Modalities of Assessing the Disease Profile of COPD Instead of Pulmonary Function Testing Under COVID-19 Pandemic [Letter]. [PDF]

Int J Chron Obstruct Pulmon Dis, 2022
Teramoto S.
europepmc   +1 more source

Evaluating the Antiviral Efficacy of Encapsulated PKC Inhibitor BIM‐I against influenza A Virus Infection

Advanced Healthcare Materials, EarlyView.
This study explores nanoparticle delivery of the protein kinase C inhibitor bisindolylmaleimide‐I (BIM‐I) to combat influenza A virus infections. Encapsulation in biodegradable PLGA nanoparticles improved safety while maintaining the compound's strong antiviral activity.
Laura Klement, Jana Ismail, Josefine Schroeder, Amod Godbole, Johanna Schreiber, Christine Weber, Zoltan Cseresnyes, Marc T. Figge, Bettina Löffler, Ulrich S. Schubert, Stephanie Schubert, Christina Ehrhardt, Carsten Hoffmann   +12 more
wiley   +1 more source

Pulmonary Function Testing

Southwest Respiratory and Critical Care Chronicles, 2014
Hawa Edriss, Gilbert Berdine
doaj  

Challenges and the Future of Pulmonary Function Testing in Chronic Obstructive Pulmonary Disease (COPD): Toward Earlier Diagnosis of COPD. [PDF]

Tuberc Respir Dis (Seoul)
Kim SH, Han MK.
europepmc   +1 more source

Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy

Advanced Materials, EarlyView.
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa, Gracia Mendoza, Silvia Irusta, Manuel Arruebo   +3 more
wiley   +1 more source

Pulmonary Function Testing & Interpretation

Annals of Thoracic Medicine, 2012
M Ayaz Khan
doaj  

Prevalence of chronic respiratory diseases diagnosed by pulmonary function testing: a cross-sectional study. [PDF]

Ann Med Surg (Lond)
Alnoor SAM, Elhag OEY, Ali NMA, Yousif YOE, Mohamed AAE, Saad AHS, Mohamed AAA.   +6 more
europepmc   +1 more source